CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.

Autor: Monif M; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia; Department of Physiology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: Mastura.Monif@Monash.edu., Sequeira RP; Department of Neuroscience, Monash University, Melbourne, VIC, Australia., Muscat A; Department of Neuroscience, Monash University, Melbourne, VIC, Australia., Stuckey S; Department of Neuroscience, Monash University, Melbourne, VIC, Australia., Sanfilippo PG; Department of Neuroscience, Monash University, Melbourne, VIC, Australia., Minh V; Department of Neurology, Alfred Health, Melbourne, VIC, Australia; School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Melbourne, VIC, Australia., Loftus N; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Voo V; Department of Neuroscience, Monash University, Melbourne, VIC, Australia., Fazzolari K; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia., Moss M; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Maltby VE; John Hunter Hospital, Department of Neurology, New Lambton Heights, NSW, Australia; School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia., Nguyen AL; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia., Wesselingh R; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Seery N; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Nesbitt C; Department of Neurology, Alfred Health, Melbourne, VIC, Australia; Department of Neurology, Barwon Health, Melbourne, VIC, Australia., Baker J; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Dwyer C; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia., Taylor L; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia., Rath L; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Van der Walt A; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Marriott M; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, Eastern Health, Melbourne, VIC, Australia., Kalincik T; Department of Neurology, Melbourne Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia., Lechner-Scott J; John Hunter Hospital, Department of Neurology, New Lambton Heights, NSW, Australia; School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia., O'Brien TJ; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia., Butzkueven H; Department of Neuroscience, Monash University, Melbourne, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia.

Publikováno v: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Aug; Vol. 265, pp. 110304. Date of Electronic Publication: 2024 Jul 02.

Baby brains need bugs: evaluating the role of early-life microbiota in modulating brain development from c-section mice

Autor: Tessier, C., Loftus, N., Barnes, A., Swann, J., Cryan, J., Aburto, M. Rodriguez

Publikováno v: In Neuroscience Applied 2022 1 Supplement 1

The effects of a group exercise and education programme on symptoms and physical fitness in patients with fibromyalgia: a prospective observational cohort study.

Autor: Loftus N; Therapies Department, Broadgreen Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; The Walton Centre NHS Foundation Trust, Pain Management Programme Department, Liverpool, UK., Dobbin N; Department of Health Professions, Manchester Metropolitan University, Manchester, UK., Crampton JS; Department of Health Professions, Manchester Metropolitan University, Manchester, UK.

Publikováno v: Disability and rehabilitation [Disabil Rehabil] 2022 Jul; Vol. 44 (15), pp. 3860-3867. Date of Electronic Publication: 2021 Mar 01.

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson's Disease.

Autor: Pons ML; IRMB-PPC, INM, CHU Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France.; Shimadzu Corporation, Duisburg, Germany., Loftus N; Shimadzu Corporation, Manchester, United Kingdom., Vialaret J; IRMB-PPC, INM, CHU Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France., Moreau S; Shimadzu Corporation, Duisburg, Germany., Lehmann S; IRMB-PPC, INM, CHU Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France., Hirtz C; IRMB-PPC, INM, CHU Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France.

Publikováno v: Frontiers in aging neuroscience [Front Aging Neurosci] 2022 Mar 31; Vol. 14, pp. 818606. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.